Publication | Closed Access

Ritanserin, a potent serotonin 2A receptor antagonist, represses MEK/ERK signalling pathway to restore PAX6 production and function in aniridia-like cellular model

Signal TransductionMedicinePax6 ProductionNeurotransmitterReceptor AntagonistPharmacotherapyPotent Serotonin 2AMolecular NeurobiologyPharmacologyCell BiologyCell Signaling